Delta-Fly Pharma, Inc.

¥59.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4598Healthcare
Country Japan
PE (Fwd) •••
TSR 8Y CAGR (40.86%)
Div yield —
ROE (736.84%)
Biotechnology
Beta (5Y) (0.72)
PE TTM —
TSR TTM (85.99%)
Mkt cap ¥1.138B
ROIC (456.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥61
3.79%
(57.70%)
Sell 8|7|3|6|10
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
1.18
1.21
1.34
1.30
15.14%
10.01%
18.76%
11.43%
Revenue¥M
56.78
58.43
60.07
58.81
12.50%
10.39%
11.46%
3.17%
Peers (US$7.224M)
Cap (US$)
PE
6.306M
66.20x
Capital
TTM
5Y
10Y
Leveragex
0.898
0.041
0.038
EBIT/Intx
1.113
0.123
0.109
Own earn%
(238.87)
128.67
105.16
Sh yield%
17.77
41.27
39.03
Owners
Insiders/Inst%
1.08
63.62
Short interest%
2.17
SBC / revenue%
1.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
16–24
$1 testx
—
Incr. ROIC%
15